Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

19 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Management of Autoimmune Encephalitis in a 7-Year-Old Child With CTLA-4 Haploinsufficiency and AMPA Receptor Antibodies: A Case Report.
Quaak MSW, Buijze MSJS, Verhoeven VJM, Vermont C, Buddingh EP, Heredia M, Samsom JN, Titulaer MJ, van Rossum AM, Kamphuis S, Neuteboom RF. Quaak MSW, et al. Among authors: buijze msjs. Neurol Neuroimmunol Neuroinflamm. 2024 Jul;11(4):e200254. doi: 10.1212/NXI.0000000000200254. Epub 2024 May 10. Neurol Neuroimmunol Neuroinflamm. 2024. PMID: 38728609 Free PMC article.
Early MRI diagnosis of Sturge Weber Syndrome type 1 in infants.
Catsman-Berrevoets CE, Koudijs SM, Buijze MSJ, de Laat PCJ, Pasmans SGMA, Dremmen MHG. Catsman-Berrevoets CE, et al. Among authors: buijze msj. Eur J Paediatr Neurol. 2022 May;38:66-72. doi: 10.1016/j.ejpn.2022.04.002. Epub 2022 Apr 13. Eur J Paediatr Neurol. 2022. PMID: 35461064 Free article.
Ixazomib Treatment of IgA Multiple Myeloma With Hyperviscosity Syndrome.
Boiten HJ, Buijze M, Zweegman S, Levin MD. Boiten HJ, et al. Among authors: buijze m. Clin Lymphoma Myeloma Leuk. 2020 Nov;20(11):e832-e835. doi: 10.1016/j.clml.2020.06.016. Epub 2020 Jun 27. Clin Lymphoma Myeloma Leuk. 2020. PMID: 32690387 Free article. No abstract available.
Chemopreventive targeted treatment of head and neck precancer by Wee1 inhibition.
van Harten AM, de Boer DV, Martens-de Kemp SR, Buijze M, Ganzevles SH, Hunter KD, Leemans CR, van Beusechem VW, Wolthuis RMF, de Menezes RX, Brakenhoff RH. van Harten AM, et al. Among authors: buijze m. Sci Rep. 2020 Feb 11;10(1):2330. doi: 10.1038/s41598-020-58509-2. Sci Rep. 2020. PMID: 32047167 Free PMC article.
Preclinical evidence for an effective therapeutic activity of FL118, a novel survivin inhibitor, in patients with relapsed/refractory multiple myeloma.
Holthof LC, van der Horst HJ, van Hal-van Veen SE, Ruiter RWJ, Li F, Buijze M, Andersen MN, Yuan H, de Bruijn J, van de Donk NWCJ, Lokhorst HM, Zweegman S, Groen RWJ, Mutis T. Holthof LC, et al. Among authors: buijze m. Haematologica. 2020 Jan 31;105(2):e80-e83. doi: 10.3324/haematol.2018.213314. Print 2020. Haematologica. 2020. PMID: 31123033 Free PMC article. No abstract available.
Targeting PLK1 as a novel chemopreventive approach to eradicate preneoplastic mucosal changes in the head and neck.
de Boer DV, Martens-de Kemp SR, Buijze M, Stigter-van Walsum M, Bloemena E, Dietrich R, Leemans CR, van Beusechem VW, Braakhuis BJM, Brakenhoff RH. de Boer DV, et al. Among authors: buijze m. Oncotarget. 2017 May 16;8(58):97928-97940. doi: 10.18632/oncotarget.17880. eCollection 2017 Nov 17. Oncotarget. 2017. PMID: 29228663 Free PMC article.
19 results